Daratumumab plus lenalidomide and dexamethasone for untreated myeloma - Facon, Thierry; Kumar, Shaji; Plesner, Torben; Orlowski, Robert Z.; Moreau, Philippe; Bahlis, Nizar; Basu, Supratik; Nahi, Hareth; Hulin, Cyrille; Quach, Hang; Goldschmidt, Hartmut; O’Dwyer, Michael; et al. (The New England journal of medicine, 2019)
Gesehen am 04.10.2019